Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Modecainide is metabolite of Encainide, is an antiarrhythmic agent.
Description | Modecainide is metabolite of Encainide, is an antiarrhythmic agent. |
In vivo | O-demethylated Encainide (MJ 9444) and 3-O-methoxy Encainide (MJ 14030), on cardiac conduction is studied by recording His bundle potentials in isolated perfused rabbit hearts and Purkinje and muscle conduction in vivo in dog hearts after destruction of the atrioventricular node. Both metabolites are 4 to 15 times more potent than Encainide in slowing conduction through the atria, the AV-node and the His-Purkinje system of the rabbit heart. In the dog, Encainide (0.8-3.2 mg/kg i.v.) slows conduction of extrasystoles in both Purkinje and muscle at all coupling intervals, increases the effective refractory period and the functional refractory period of the Purkinje pathway[1]. |
Synonyms | BMY 40327, MJ 14030 |
Molecular Weight | 368.47 |
Formula | C22H28N2O3 |
CAS No. | 81329-71-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Modecainide 81329-71-7 Others BMY-40327 MJ14030 BMY 40327 MJ 14030 MJ-14030 BMY40327 inhibitor inhibit